CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
| CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
|---|---|---|---|---|---|---|
| C22304 | BRD-K62577212 | BRD-K62577212 | -- | -- | -- | Details |
| C22305 | BRD-K62578746 | BRD-K62578746 | -- | -- | -- | Details |
| C22306 | BRD-K62581435 | 3-MPPI | ADRA1A | Adrenergic receptor ligand | -- | Details |
| C22307 | BRD-K62584372 | BRD-K62584372 | -- | -- | -- | Details |
| C22308 | BRD-K62586643 | JAS07-001 | -- | -- | JAS-07-001 | Details |
| C22309 | BRD-K62590692 | BRD-K62590692 | -- | -- | -- | Details |
| C22310 | BRD-K62590938 | BRD-K62590938 | -- | -- | -- | Details |
| C22311 | BRD-K62595167 | BRD-K62595167 | -- | -- | -- | Details |
| C22312 | BRD-K62597218 | BRD-K62597218 | -- | -- | -- | Details |
| C22313 | BRD-K62599086 | BRD-K62599086 | -- | -- | -- | Details |
| C22314 | BRD-K62600822 | BRD-K62600822 | -- | -- | -- | Details |
| C22315 | BRD-K62601469 | BRD-K62601469 | -- | -- | -- | Details |
| C22316 | BRD-K62602051 | BRD-K62602051 | -- | -- | -- | Details |
| C22317 | BRD-K62607865 | aztreonam | -- | -- | -- | Details |
| C22318 | BRD-K62609077 | scoulerine | ADRA1D; ADRA2A; GABRA1 | GABA receptor antagonist; Serotonin receptor antagonist; Adrenergic receptor antagonist | -- | Details |
| C22319 | BRD-K62612761 | BRD-K62612761 | -- | -- | -- | Details |
| C22320 | BRD-K62620616 | BRD-K62620616 | -- | -- | -- | Details |
| C22321 | BRD-K62620932 | 1-HYDROXYANTHRAQUINONE | -- | -- | -- | Details |
| C22322 | BRD-K62621335 | SRPIN-340 | -- | -- | -- | Details |
| C22323 | BRD-K62621376 | BRD-K62621376 | -- | -- | -- | Details |
| C22324 | BRD-K62624148 | BRD-K62624148 | -- | -- | -- | Details |
| C22325 | BRD-K62624932 | BRD-K62624932 | -- | -- | -- | Details |
| C22326 | BRD-K62625902 | BRD-K62625902 | -- | -- | -- | Details |
| C22327 | BRD-K62627073 | erismo-ester | -- | -- | -- | Details |
| C22328 | BRD-K62627508 | RG-7388 | -- | -- | idasanutlin | Details |
| C22329 | BRD-K62628154 | BRD-K62628154 | -- | -- | -- | Details |
| C22330 | BRD-K62638625 | BRD-K62638625 | -- | -- | -- | Details |
| C22331 | BRD-K62650632 | BRD-K62650632 | -- | -- | -- | Details |
| C22332 | BRD-K62657501 | BRD-K62657501 | -- | -- | -- | Details |
| C22333 | BRD-K62659610 | BRD-K62659610 | -- | -- | -- | Details |
| C22334 | BRD-K62659735 | BRD-K62659735 | -- | -- | -- | Details |
| C22335 | BRD-K62676049 | BRD-K62676049 | -- | -- | -- | Details |
| C22336 | BRD-K62676709 | guanethidine | -- | -- | -- | Details |
| C22337 | BRD-K62682892 | BRD-K62682892 | -- | -- | -- | Details |
| C22338 | BRD-K62683350 | MW-STK33-4A | -- | -- | -- | Details |
| C22339 | BRD-K62685538 | triptorelin | GNRHR | Gonadotropin releasing factor hormone receptor agonist | -- | Details |
| C22340 | BRD-K62687522 | BRD-K62687522 | -- | -- | -- | Details |
| C22341 | BRD-K62689646 | BRD-K62689646 | -- | -- | -- | Details |
| C22342 | BRD-K62692910 | BRD-K62692910 | -- | -- | -- | Details |
| C22343 | BRD-K62695275 | BRD-K62695275 | -- | -- | -- | Details |
| C22344 | BRD-K62697007 | BRD-K62697007 | -- | -- | -- | Details |
| C22345 | BRD-K62698674 | BRD-K62698674 | -- | -- | -- | Details |
| C22346 | BRD-K62702428 | BRD-K62702428 | -- | -- | -- | Details |
| C22347 | BRD-K62707745 | BRD-K62707745 | -- | -- | -- | Details |
| C22348 | BRD-K62708569 | BRD-K62708569 | -- | -- | -- | Details |
| C22349 | BRD-K62714403 | BRD-K62714403 | -- | -- | -- | Details |
| C22350 | BRD-K62714735 | BRD-K62714735 | -- | -- | -- | Details |
| C22351 | BRD-K62716919 | BRD-K62716919 | -- | -- | -- | Details |
| C22352 | BRD-K62717630 | BRD-K62717630 | -- | -- | -- | Details |
| C22353 | BRD-K62718031 | BRD-K62718031 | -- | -- | -- | Details |
| C22354 | BRD-K62719675 | BRD-K62719675 | -- | -- | -- | Details |
| C22355 | BRD-K62724755 | BRD-K62724755 | -- | -- | -- | Details |
| C22356 | BRD-K62726279 | BRD-K62726279 | -- | -- | -- | Details |
| C22357 | BRD-K62732905 | BRD-K62732905 | -- | -- | -- | Details |
| C22358 | BRD-K62732912 | BRD-K62732912 | -- | -- | -- | Details |
| C22359 | BRD-K62734359 | BRD-K62734359 | -- | -- | -- | Details |
| C22360 | BRD-K62734952 | arglabin | FNTA; NFKB1 | Farnesyltransferase inhibitor | -- | Details |
| C22361 | BRD-K62736196 | guanaben-acetate | ADRA2A; ADRA2B | Adrenergic receptor agonist | -- | Details |
| C22362 | BRD-K62737565 | gabapentin | CACNA1B; CACNA2D1; CACNA2D2 | Calcium channel blocker | -- | Details |
| C22363 | BRD-K62743802 | BRD-K62743802 | -- | -- | -- | Details |
| C22364 | BRD-K62744999 | BRD-K62744999 | -- | -- | -- | Details |
| C22365 | BRD-K62748060 | BRD-K62748060 | -- | -- | -- | Details |
| C22366 | BRD-K62748479 | BRD-K62748479 | -- | -- | -- | Details |
| C22367 | BRD-K62753164 | BRD-K62753164 | -- | -- | -- | Details |
| C22368 | BRD-K62758843 | BRD-K62758843 | -- | -- | -- | Details |
| C22369 | BRD-K62761144 | BRD-K62761144 | -- | -- | -- | Details |
| C22370 | BRD-K62762455 | RU-58841 | AR | Androgen receptor antagonist | -- | Details |
| C22371 | BRD-K62767164 | BRD-K62767164 | -- | -- | -- | Details |
| C22372 | BRD-K62768020 | BRD-K62768020 | -- | -- | -- | Details |
| C22373 | BRD-K62768599 | BRD-K62768599 | -- | -- | -- | Details |
| C22374 | BRD-K62768824 | BRD-K62768824 | -- | -- | -- | Details |
| C22375 | BRD-K62771544 | BRD-K62771544 | -- | -- | -- | Details |
| C22376 | BRD-K62771975 | BRD-K62771975 | -- | -- | -- | Details |
| C22377 | BRD-K62773636 | BRD-K62773636 | -- | -- | -- | Details |
| C22378 | BRD-K62774106 | BRD-K62774106 | -- | -- | -- | Details |
| C22379 | BRD-K62780697 | BRD-K62780697 | -- | -- | -- | Details |
| C22380 | BRD-K62781263 | BRD-K62781263 | -- | -- | -- | Details |
| C22381 | BRD-K62782754 | tiotropium | CHRM3 | Acetylcholine receptor antagonist | -- | Details |
| C22382 | BRD-K62792802 | LY-83583 | GUCY1A2 | Guanylyl cyclase inhibitor | -- | Details |
| C22383 | BRD-K62794454 | BRD-K62794454 | -- | -- | -- | Details |
| C22384 | BRD-K62795540 | BRD-K62795540 | -- | -- | -- | Details |
| C22385 | BRD-K62800316 | BRD-K62800316 | -- | -- | -- | Details |
| C22386 | BRD-K62801835 | BRD-K62801835 | -- | -- | -- | Details |
| C22387 | BRD-K62803063 | BRD-K62803063 | -- | -- | -- | Details |
| C22388 | BRD-K62804700 | BRD-K62804700 | -- | -- | -- | Details |
| C22389 | BRD-K62807053 | BRD-K62807053 | -- | -- | -- | Details |
| C22390 | BRD-K62810658 | PD-98059 | MAP2K1 | MEK inhibitor; MAP kinase inhibitor | -- | Details |
| C22391 | BRD-K62814224 | BRD-K62814224 | -- | -- | -- | Details |
| C22392 | BRD-K62814476 | BMS-265246 | CDK2; CDK1 | CDK inhibitor | -- | Details |
| C22393 | BRD-K62814487 | SR-1664 | -- | -- | -- | Details |
| C22394 | BRD-K62818989 | BRD-K62818989 | -- | -- | -- | Details |
| C22395 | BRD-K62820230 | BRD-K62820230 | -- | -- | -- | Details |
| C22396 | BRD-K62833556 | BRD-K62833556 | -- | -- | -- | Details |
| C22397 | BRD-K62833799 | BRD-K62833799 | -- | -- | -- | Details |
| C22398 | BRD-K62836482 | BRD-K62836482 | -- | -- | -- | Details |
| C22399 | BRD-K62836687 | BRD-K62836687 | -- | -- | -- | Details |
| C22400 | BRD-K62839271 | BRD-K62839271 | -- | -- | -- | Details |
| C22401 | BRD-K62841356 | BRD-K62841356 | -- | -- | -- | Details |
| C22402 | BRD-K62841603 | BRD-K62841603 | -- | -- | -- | Details |
| C22403 | BRD-K62846431 | BRD-K62846431 | -- | -- | -- | Details |